KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $16.8 billion.

  • Boston Scientific's Total Non-Current Liabilities rose 820.77% to $16.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.8 billion, marking a year-over-year increase of 820.77%. This contributed to the annual value of $16.8 billion for FY2025, which is 820.77% up from last year.
  • As of Q4 2025, Boston Scientific's Total Non-Current Liabilities stood at $16.8 billion, which was up 820.77% from $16.7 billion recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Total Non-Current Liabilities registered a high of $16.8 billion during Q4 2025, and its lowest value of $12.4 billion during Q3 2022.
  • For the 5-year period, Boston Scientific's Total Non-Current Liabilities averaged around $14.1 billion, with its median value being $13.5 billion (2021).
  • In the last 5 years, Boston Scientific's Total Non-Current Liabilities surged by 4489.27% in 2021 and then plummeted by 598.44% in 2023.
  • Boston Scientific's Total Non-Current Liabilities (Quarter) stood at $13.4 billion in 2021, then fell by 3.93% to $12.9 billion in 2022, then rose by 6.05% to $13.6 billion in 2023, then rose by 13.81% to $15.5 billion in 2024, then increased by 8.21% to $16.8 billion in 2025.
  • Its Total Non-Current Liabilities was $16.8 billion in Q4 2025, compared to $16.7 billion in Q3 2025 and $16.5 billion in Q2 2025.